101 related articles for article (PubMed ID: 20491587)
1. Mesenchymal stem cells overexpressing ephrin-b2 rapidly adopt an early endothelial phenotype with simultaneous reduction of osteogenic potential.
Duffy GP; D'Arcy S; Ahsan T; Nerem RM; O'Brien T; Barry F
Tissue Eng Part A; 2010 Sep; 16(9):2755-68. PubMed ID: 20491587
[TBL] [Abstract][Full Text] [Related]
2. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs.
Rytlewski JA; Alejandra Aldon M; Lewis EW; Suggs LJ
Microvasc Res; 2015 May; 99():26-35. PubMed ID: 25711526
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cell Spheroids Retain Osteogenic Phenotype Through α2β1 Signaling.
Murphy KC; Hoch AI; Harvestine JN; Zhou D; Leach JK
Stem Cells Transl Med; 2016 Sep; 5(9):1229-37. PubMed ID: 27365484
[TBL] [Abstract][Full Text] [Related]
6. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
[TBL] [Abstract][Full Text] [Related]
7. Regulation of signaling interactions and receptor endocytosis in growing blood vessels.
Pitulescu ME; Adams RH
Cell Adh Migr; 2014; 8(4):366-77. PubMed ID: 25482636
[TBL] [Abstract][Full Text] [Related]
8. Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.
Tae N; Lee S; Kim O; Park J; Na S; Lee JH
Oncotarget; 2017 Jun; 8(24):38886-38901. PubMed ID: 28418925
[TBL] [Abstract][Full Text] [Related]
9. Functional ephrin-B2 expression for promotive interaction between arterial and venous vessels in postnatal neovascularization.
Hayashi S; Asahara T; Masuda H; Isner JM; Losordo DW
Circulation; 2005 May; 111(17):2210-8. PubMed ID: 15851594
[TBL] [Abstract][Full Text] [Related]
10. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF.
Liu L; Gao J; Yuan Y; Chang Q; Liao Y; Lu F
Cell Biol Int; 2013 Jun; 37(6):551-60. PubMed ID: 23505143
[TBL] [Abstract][Full Text] [Related]
12. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
13. [EphrinB2 gene transfection promotes the differentiation of bone marrow mesenchymal stem cells into vascular endothelial cells].
Xu X; Tang LQ; Ma SC; Gao LJ; Huang XQ; Fan WM; Ma YL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):790-4. PubMed ID: 18504206
[TBL] [Abstract][Full Text] [Related]
14. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
[TBL] [Abstract][Full Text] [Related]
15. Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels.
Choi M; Lee HS; Naidansaren P; Kim HK; O E; Cha JH; Ahn HY; Yang PI; Shin JC; Joe YA
Int J Biochem Cell Biol; 2013 Mar; 45(3):560-70. PubMed ID: 23246593
[TBL] [Abstract][Full Text] [Related]
16. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.
Cowan CA; Yokoyama N; Saxena A; Chumley MJ; Silvany RE; Baker LA; Srivastava D; Henkemeyer M
Dev Biol; 2004 Jul; 271(2):263-71. PubMed ID: 15223333
[TBL] [Abstract][Full Text] [Related]
17. Engineered Fibrin Gels for Parallel Stimulation of Mesenchymal Stem Cell Proangiogenic and Osteogenic Potential.
Murphy KC; Hughbanks ML; Binder BY; Vissers CB; Leach JK
Ann Biomed Eng; 2015 Aug; 43(8):2010-21. PubMed ID: 25527322
[TBL] [Abstract][Full Text] [Related]
18. Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells.
van Gastel N; Torrekens S; Roberts SJ; Moermans K; Schrooten J; Carmeliet P; Luttun A; Luyten FP; Carmeliet G
Stem Cells; 2012 Nov; 30(11):2460-71. PubMed ID: 22911908
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor does not accelerate endothelial differentiation of human mesenchymal stem cells.
Galas RJ; Liu JC
J Cell Physiol; 2014 Jan; 229(1):90-6. PubMed ID: 23794239
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
